Although this effect might be protective against infection and sepsis [140, 141], the presence of apoC1 was shown to enhance atherosclerotic lesion size and inflammatory status of the plaque in a genetically engineered mice where atherosclerosis was induced by repeated LPS injections [142]. This evidence concerns the gene APOC1 and atherosclerosis.